Time & Date: 1 September, 14:30 – 15:30 CEST
Speakers & Presentations:
S. Montolío-Marzo SPAIN
14:32 Advantages of Optical Coherence Tomography as a High Dynamic Range Imaging
Modality in Subretinal Hyperreflective Material.
R.M. Pinardel SPAIN
14:37 Fluid quantification predicts visual outcomes in Naïve Neovascular Age-related Macular Degeneration: A real-world national database study
D. Rego-Lorca SPAIN
14:42 Consequences of treatment delay induce by COVID-19 lockdown on neovascular AMD patients. Where we are one year later.
G. Staurenghi ITALY
14:47 Real-world evidence study on effectiveness, adherence, needs, and cost of anti-VEGF therapies in neovascular age-related macular degeneration in Italy: the RADIANCE study
F. Goldbach AUSTRIA
14:52 Human Expert Grading versus Automated Quantification of Fluid Volumes in nAMD, DME and BRVO
J. Zarranz-Ventura SPAIN
14:57 Fight Retinal Blindness SPAIN: Visual outcomes, number of injections and visits in naïve and previously treated Neovascular Age-related Macular Degeneration eyes. A National database study.
K. Schmidto USA
15:02 RT011 (deuterium-reinforced docosahexaenoic acid, D-DHA) protects against geographic atrophy-like retinal degeneration in an iron-induced murine oxidative stress model